HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case–control analyses

By Millikan Robert  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 309-312

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis

By Lu Pei-Hua  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 597-598

Springer Publishing Company

Access to resources Recommend Favorite

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

By Lu Su  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

p53 codon 72 polymorphism and breast cancer risk: A meta-analysis

By        

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1397-1402

Spandidos Publications

Access to resources Recommend Favorite

COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States)

By Sansbury Leah   Millikan Robert   Schroeder Jane   North Kari   Moorman Patricia   Keku Temitope   Cotret Allan   Player Jon   Sandler Robert  

Cancer Causes and Control, Vol. 17, Iss. 3, 2006-04 ,pp. : 257-266

Springer Publishing Company

Access to resources Recommend Favorite